Niagen Bioscience, Inc. (NAGE)

Niagen Bioscience Stock Forecast

Stock Price Forecast

The 3 analysts that cover Niagen Bioscience stock have a consensus rating of "Strong Buy" and an average price target of $16, which forecasts a 256.74% increase in the stock price over the next year. The lowest target is $12 and the highest is $23.

Price Target: $16 (+256.74%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$16	$13	$23
Change	+167.56%	+256.74%	+189.86%	+412.82%

Analyst Ratings

The average analyst rating for Niagen Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	3	3	3	3	3	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Susan Anderson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $13	Strong Buy	Maintains	$13	+189.86%	Mar 31, 2026
Susan Anderson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $14 → $13	Strong Buy	Maintains	$14 → $13	+189.86%	Mar 5, 2026
Susan Anderson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $16 → $14	Strong Buy	Maintains	$16 → $14	+212.15%	Nov 5, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $11 → $12	Strong Buy	Maintains	$11 → $12	+167.56%	Aug 11, 2025
Susan Anderson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $13 → $16	Strong Buy	Maintains	$13 → $16	+256.74%	Jun 10, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

150.79M

Increased by 16.51%

from 129.42M

Revenue Next Year

172.77M

Increased by 14.58%

from 150.79M

EPS This Year

0.28

Increased by 38.98%

from 0.20

EPS Next Year

0.35

Increased by 26.61%

from 0.28

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	67.45M	72.05M	83.57M	99.60M	129.42M	150.79M	172.77M
Revenue Growth	13.83%	6.82%	15.99%	19.18%	29.95%	16.51%	14.58%
EPS	-0.40	-0.24	-0.07	0.11	0.20	0.28	0.35
EPS Growth	-	-	-	-	81.82%	38.98%	26.61%
Forward PE	-	-	-	-	-	16.14	12.75
No. Analysts	-	-	-	-	-	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	163.1M	183.0M
Avg	150.8M	172.8M
Low	141.1M	159.7M

Revenue Growth

Revenue Growth	2026	2027	2028
High	26.0%	21.3%
Avg	16.5%	14.6%
Low	9.0%	5.9%

EPS Forecast

EPS	2026	2027	2028
High	0.35	0.39
Avg	0.28	0.35
Low	0.23	0.31

EPS Growth

EPS Growth	2026	2027	2028
High	73.3%	39.8%
Avg	39.0%	26.6%
Low	12.7%	12.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.